AzTrials
AzTrials

Eye ChangeNCT05626075

Correlation Between Corneal Topographic Patterns and Refractive Status Of The Eye in Sohag City,Egypt

A study testing Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions. in people with Eye Change, run by Sohag University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To evaluate corneal topographic pattern \& its correlation with refractive status of the eye . Read more about this study

Who is it for?
Ages 15 years and olderHealthy volunteers can take part
Conditions the study is for
Eye Change
What is being tested?
Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
22 Sep 2022to Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Patients aging more than 15 years old
  • All patients are with visual acuity (uncorrected, with habitual correction, and best spectacle correction).
  • There is no restrictions on the range and regularity of keratometry.

Who cannot join

  • Patients with a history of any trauma to the eye.
  • Patients with recent contact lens wear.
  • history of ocular surgery .
  • Patients with distance corrected visual acuity or abnormal retinoscopy examination (e.g., scissoring reflex).
  • 5. If there was any error in reading the topographic map. 6. Patients with anemotropic refraction.

Trial locations and contacts

1 site in 1 country.

Mohamed Iqbal, MD.PhD contact

00201068559840

dr_m_iqbal@yahoo.com

Egypt1 site, 1 recruiting
  • Facultyof medicine

    Sohag, 82425

    Mohamed Iqbal, Md.PhD, 00201068559840, dr_m_iqbal@yahoo.com

    Recruiting

Other trials in Egypt

About this study

To evaluate corneal topographic pattern \& its correlation with refractive status of the eye .

Read the detailed description

This study will be established in The Future Center for refractive surgery, Sohag, Egypt.

This study will include 100 eyes of patients aged over 15 years. All patients were subjected to topography imaging.

Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.

The scheimpflug principle describes the optical imaging condition when the plane of an object is not parallel to the film of the camera and has to cut each other in one line or one point of intersection with the advantage to achieve wide depth of focus.

Scheimpflug imaging attains a wide and high depth-of-focus , providing sharp images that include information from an anterior corneal surface through to the posterior crystalline capsule; this depends mainly on media transparency and pupil size .

Conditions
Eye Change
Being tested
Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.
Keywords
Topographic, visual acuity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.Diagnostic test

    Also called The scheimpflug principle describes the optical imaging condition

    Scheimpflug imaging attains a wide and high depth-of-focus , providing sharp images that include information from an anterior corneal surface through to the posterior crystalline capsule

Study groups in NCT05626075
Study groupRoleWhat they receive
group Low MyopiaExperimental1. Patients with low myopia aging more than 15 years old 2. All patients are with visual acuity (uncorrected, with habitual correction, and best spectacle correction). 3. There is no restrictions on the range and regularity of keratometry
Receives: Diagnostic Test: Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.
group high myopiaExperimental1. Patients with high myopia aging more than 15 years old 2. All patients are with visual acuity (uncorrected, with habitual correction, and best spectacle correction). 3. There is no restrictions on the range and regularity of keratometry
Receives: Diagnostic Test: Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.
group HypermetropiaExperimental1. Patients with hypermetropia aging more than 15 years old 2. All patients are with visual acuity (uncorrected, with habitual correction, and best spectacle correction). 3. There is no restrictions on the range and regularity of keratometry
Receives: Diagnostic Test: Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.
group mixed astigmatismExperimental1. Patients with mixed astigmatism aging more than 15 years old 2. All patients are with visual acuity (uncorrected, with habitual correction, and best spectacle correction). 3. There is no restrictions on the range and regularity of keratometry
Receives: Diagnostic Test: Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Thickness

    Topographic values using Oculus Pentacam®

    Measured: 3 months after begin of study

  2. degree of astigmatism in D

    Topographic values using Oculus Pentacam®

    Measured: 3 months after begin of study

  3. maximum keratometry

    Topographic values using Oculus Pentacam®

    Measured: 3 months after begin of study

  4. front and back elevation of the apex (um).

    Topographic values using Oculus Pentacam®

    Measured: 3 months after begin of study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2022
  2. Study start22 Sep 2022
  3. Primary completionDec 2022 (estimated)
  4. Study completionMar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05626075
Sponsor's protocol ID
Soh-Med-22-07-2014
Status last verified
Nov 2022
First submitted
12 Oct 2022
Last updated
23 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Using Oculus Pentacam® which is s a rotating Scheimpflug camera. The rotational measuring procedure generates Scheimpflug images in three dimensions. in people with Eye Change, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Iqbal, MD.PhD (00201068559840, dr_m_iqbal@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Thickness (time frame: 3 months after begin of study). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in